When is a Name More Than Just a Name?
This article is part of Wolf Greenfield's design patents page. To learn more about design patents, click here. The Court of Appeals for the Federal Circuit was tasked with determining whether a design...
Patent (6)
Experts Connect™ No. 15: Exploring the Reasons that Guiding Case No. 20 Lost Its Guiding Effect
An article titled "Exploring the Reasons that Guiding Case No. 20 Lost Its Guiding Effect" was published in China Law Connect, a journal of Stanford Law Schools' China Guiding Cases Project. Read more...
Boston Patent Law Association Response to Request for Comments on Administrative Updates to the General Requirements Bulletin for Admission to the Examination for Registration to Practice...
Jonathan Roses co-authored on behalf of the Boston Patent Law Association's (BPLA’s) Patent Office Practice Committee a May 2021 Response to USPTO Request for Comments on proposed updates to the USPTO...
Drafting Clearer Patent Claims After Federal Circuit L'Oreal Ruling
(as published by Law360) The U.S. Court of Appeals for the Federal Circuit recently highlighted an important rule of patent claim construction: that claim limitations should be construed in a way that...
Intellectual Property for Startups: Building a Toolkit to Protect Your Products and Design
(as published by IPWatchdog) “Many startups make the mistake of ignoring the value of non-patent intellectual property…. A company’s brand can be immensely valuable in the marketplace.”
Boston Patent Law Association Response to a USPTO Notice of Proposed Rulemaking on Bayh-Dole Regulations
Jonathan Roses was the lead author on behalf of the Boston Patent Law Association’s (BPLA’s) Patent Office Practice and Licensing Committees of an April 2021 Response to a Notice of Proposed Rulemakin...
Discretionary Denial at the PTAB Based on Parallel Litigation
Discretionary denial has been a hot topic at the PTAB. On Wednesday, February 24th, Wolf Greenfield hosted a webinar to discuss discretionary denial at the PTAB, and in particular, discretionary denia...
Boston Patent Law Association Response to USPTO Request for Comments on the National Strategy for Expanding American Innovation
Jonathan Roses was the lead author on behalf of the Boston Patent Law Association's (BPLA’s) Patent Office Practice and ad hoc Diversity & Inclusion Committees of a February 2021 Response to USPTO...
Expert Declarations in Inter Partes Review Proceedings Must Do More Than Create Noise: PTAB Silences Challenge to Patented Method for Cleaning “Noisy” Genetic Data
Overview On December 11, 2020, the PTAB issued a Final Written Decision in Illumina, Inc. v. Natera, Inc., IPR2019-01201, upholding the validity of Natera Inc.’s patent for determining genetic data fr...
Protecting Pharmaceutical Exclusivity: Avoiding the Hidden Dangers of Double Patenting
An article written by Rob Sahr titled “Protecting Pharmaceutical Exclusivity: Avoiding the Hidden Dangers of Double Patenting” was published in Pharmaceutical Commerce. Read more.
Economic Considerations in Granting Injunctive Relief: Federal Circuit Partially Reverses Injunctive Relief in a Case of Willful Infringement
Overview On August 3, 2020, the United States Court of Appeals for the Federal Circuit partially reversed a District Court’s decision for a permanent injunction against 10X Genomics. Bio-Rad Laborator...
Doctrine of Equivalents in US and European Patent Law
An article written by Jonathan Roses and Alexander Lee, associate at Hoffmann Eitle, titled "Doctrine of Equivalents in US and European Patent Law" was published in The Pharma Letter. Read more (subsc...